What is the treatment for thrush?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Oral Thrush (Oropharyngeal Candidiasis)

For mild oral thrush, start with clotrimazole troches 10 mg five times daily for 7-14 days, and for moderate to severe disease, use oral fluconazole 100-200 mg daily for 7-14 days. 1

First-Line Treatment by Disease Severity

Mild Disease

  • Clotrimazole troches 10 mg five times daily for 7-14 days is the preferred topical option 1, 2
  • Miconazole mucoadhesive buccal 50-mg tablet applied to the mucosal surface over the canine fossa once daily for 7-14 days is an equally effective alternative 1
  • Nystatin suspension (100,000 U/mL) 4-6 mL four times daily OR nystatin pastilles (200,000 U each) 1-2 pastilles four times daily for 7-14 days are additional alternatives 1, 2

Moderate to Severe Disease

  • Oral fluconazole 100-200 mg daily for 7-14 days is the treatment of choice 1, 2
  • This systemic approach is more effective than topical agents for extensive disease 1
  • Fluconazole offers superior compliance compared to multiple-daily-dose topical regimens 3

Refractory or Fluconazole-Resistant Disease

When patients fail initial fluconazole therapy or have known azole-resistant organisms:

  • Itraconazole solution 200 mg once daily OR posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily for up to 28 days 1
  • Voriconazole 200 mg twice daily is an alternative 1
  • Amphotericin B deoxycholate oral suspension 100 mg/mL four times daily for azole-refractory cases 1, 4
  • Intravenous echinocandin (caspofungin 70-mg loading dose, then 50 mg daily; micafungin 100 mg daily; or anidulafungin 200-mg loading dose, then 100 mg daily) OR intravenous amphotericin B deoxycholate 0.3 mg/kg daily for severe refractory disease 1

Special Populations and Considerations

HIV/AIDS Patients

  • Antiretroviral therapy is strongly recommended to reduce recurrence of oral thrush 1
  • Chronic suppressive therapy is usually unnecessary, but if required for recurrent infection, fluconazole 100 mg three times weekly 1
  • Single-dose fluconazole 150 mg has shown 96.5% efficacy in palliative care patients with advanced cancer 5

Denture-Related Candidiasis

  • Disinfection of the denture in addition to antifungal therapy is mandatory 1
  • Failure to address denture hygiene leads to treatment failure and rapid recurrence 1

Common Pitfalls to Avoid

Do not treat asymptomatic oral colonization - this leads to unnecessary medication exposure and promotes resistance 2. Treatment is only indicated for symptomatic disease with visible lesions and patient discomfort 1.

Ensure adequate treatment duration - shorter courses (less than 7 days) have higher failure rates, particularly in immunocompromised patients 1, 2. The 7-14 day duration is evidence-based and should not be shortened 1.

Verify compliance with topical agents - troches must dissolve slowly in the mouth over 30 minutes, not be chewed or swallowed 6. Poor technique explains many treatment failures with topical therapy 3.

Consider fluconazole for patients with compliance issues - once-daily oral dosing has significantly better adherence than five-times-daily troches 3. Manual dexterity problems in elderly patients also favor systemic therapy 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Yeast Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry, 1992

Research

Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole.

Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1994

Research

Single-Dose Fluconazole Therapy for Oral Thrush in Hospice and Palliative Medicine Patients.

The American journal of hospice & palliative care, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.